Annamária Letoha

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Contribution of Syndecans to the Cellular Entry of SARS-CoV-2

Anett Hudák, Annamária Letoha, László Szilák et al. · International Journal of Molecular Sciences · 2021 · 61 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease

Anett Hudák, Annamária Letoha, Csaba Vízler et al. · International Journal of Molecular Sciences · 2022 · 30 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Novel biomarkers of mitochondrial dysfunction in Long COVID patients

Titanilla Szögi, Barbara N. Borsos, Dejana Masic et al. · GeroScience · 2024 · 28 citations · Full text

Life Sciences, Cell Biology, Infectious Diseases +17